Genscript Biotech Corporation carries a market capitalization of 3.98B, placing it among publicly traded companies globally.
| Market Cap | 3.98B |
| Enterprise Value | N/A |
Genscript Biotech Corporation's stock has declined approximately -14.15094% over the past 52 weeks. The 50-day moving average sits at 1.63, while the 200-day moving average is 1.77.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.15094% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 1.77 |
| Average Volume (20 Days) | N/A |